Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding.
Appears in 4 contracts
Sources: Research Collaboration Agreement (ArriVent Biopharma, Inc.), Research Collaboration Agreement (ArriVent Biopharma, Inc.), Research Collaboration Agreement (ArriVent Biopharma, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described above in this Section 7.3 6.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim[***]; provided, suit or proceedinghowever, [***].
Appears in 4 contracts
Sources: License Agreement, License Agreement (Kiniksa Pharmaceuticals, Ltd.), License Agreement (Kiniksa Pharmaceuticals, Ltd.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 7.4 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control enforce the defense of any such Third Party claim, suit or proceedingInfringement.
Appears in 4 contracts
Sources: Research Collaboration Agreement (ArriVent Biopharma, Inc.), Research Collaboration Agreement (ArriVent Biopharma, Inc.), Research Collaboration Agreement (ArriVent Biopharma, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 7.3.1 or 7.3.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 2 contracts
Sources: Co Development and Option Agreement (Alector, Inc.), Co Development and Option Agreement (Alector, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 5.3.1 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend bring the enforcement action; provided, however, that any award or control the defense of any such Third Party claim, suit settlement (whether by judgment or proceedingotherwise) shall be deemed to be “Net Sales” hereunder.
Appears in 2 contracts
Sources: License Agreement (Gemini Therapeutics, Inc. /DE), License Agreement (Gemini Therapeutics, Inc. /DE)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any Any recovery realized as a result of such litigation described in this Section 7.3 Sections 8.3.1, 8.3.2, or 8.3.4 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 2 contracts
Sources: Discovery Collaboration and License Agreement (Harpoon Therapeutics, Inc.), Discovery Collaboration and License Agreement (Harpoon Therapeutics, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control bring the defense of any such Third Party claim, suit or proceedingenforcement action[***].
Appears in 2 contracts
Sources: Collaboration and License Agreement (Caribou Biosciences, Inc.), Collaboration and License Agreement (Caribou Biosciences, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a written cost sharing arrangement, any recovery realized as a result of such litigation described above in this Section 7.3 8.3 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses)[*****]. Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[*****].
Appears in 2 contracts
Sources: License Agreement (AC Immune SA), License Agreement (AC Immune SA)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any Any recovery realized as a result of such litigation described in this Section 7.3 7.3.1 or Section 7.3.2 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 1 contract
Sources: Collaboration and License Agreement (Ionis Pharmaceuticals Inc)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangementSubject to Section 11.3.3, any other recovery realized as a result of such litigation described above in this Section 7.3 11.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their reasonable out-of-pocket costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any ) with any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 1 contract
Sources: Collaboration and License Agreement (Myovant Sciences Ltd.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such Infringement litigation described above in this Section 7.3 (whether by way of settlement or otherwise) 9.3 shall be first, first allocated to reimburse the Parties for their costs and expenses Costs incurred in making connection with such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses)Infringement litigation. Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 1 contract
Sources: License and Collaboration Agreement (Stoke Therapeutics, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost cost-sharing arrangement, any recovery realized as a result of such litigation described above in this Section 7.3 9.3 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making incurred with respect to such recovery litigation (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by divided equally between the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceedingParties.
Appears in 1 contract
Sources: License Agreement (Viela Bio, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 8.3.1, 8.3.2, or 8.3.4 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding.[***]
Appears in 1 contract
Sources: Discovery Collaboration and License Agreement (CytomX Therapeutics, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described above in this Section 7.3 3.2 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties each Party for their its costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses)recovery. Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceedingNeuroMetrix.
Appears in 1 contract
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any Any recovery realized as a result of such litigation described in this Section 7.3 9.5.1 or Section 9.5.2 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party [***]; provided, that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 1 contract
Sources: Discovery Collaboration and License Agreement (BICYCLE THERAPEUTICS PLC)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described in this Section 7.3 Sections 10.3.2, 10.3.1, 10.3.3, 10.3.5 or 10.3.6 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 1 contract
Sources: License and Collaboration Agreement (Spring Bank Pharmaceuticals, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any Any recovery realized as a result of such litigation described in this Section 7.3 8.3.1 and 8.3.2 (whether by way of settlement or otherwise) shall be first, first allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is reimbursements are made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[ * ].
Appears in 1 contract
Sources: License Agreement (4D Molecular Therapeutics, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any Any recovery realized as a result of such litigation described in this Section 7.3 6.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party Pxxxx that has exercised its right to defend or control bring the defense of any such Third Party claim, suit or proceedingenforcement action.
Appears in 1 contract
Sources: Software and Technology License Agreement (Ra Medical Systems, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described above in this Section 7.3 6.4 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control bring the defense of any such Third Party claim, suit or proceedingenforcement action.
Appears in 1 contract
Sources: Research Collaboration Agreement (Organovo Holdings, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any recovery realized as a result of such litigation described above in this Section 7.3 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding[***].
Appears in 1 contract
Sources: Development and Services Agreement (NeuroMetrix, Inc.)
Recovery. Except as otherwise agreed by the Parties in connection with a cost sharing arrangement, any Any recovery realized as a result of such litigation described in this Section 7.3 7.3.1, 7.3.2, or 7.3.5 (whether by way of settlement or otherwise) shall be first, allocated to reimburse the Parties for their costs and expenses in making such recovery (which amounts shall be allocated pro rata if insufficient to cover the totality of such expenses). Any remainder after such reimbursement is made shall be retained by the Party that has exercised its right to defend or control the defense of any such Third Party claim, suit or proceeding.[***]
Appears in 1 contract
Sources: Development and Option Agreement (Harpoon Therapeutics, Inc.)